HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nurulain T Zaveri Selected Research

Nociceptin Receptor

12/2020Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models.
1/2016The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
12/2015Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice.
1/2011The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
12/2009Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nurulain T Zaveri Research Topics

Disease

9Pain (Aches)
11/2021 - 12/2009
9Substance-Related Disorders (Drug Abuse)
01/2018 - 12/2009
7Tobacco Use Disorder (Nicotine Dependence)
01/2020 - 03/2013
6Parkinson Disease (Parkinson's Disease)
01/2021 - 03/2006
5Hyperalgesia
01/2018 - 05/2009
5Neoplasms (Cancer)
03/2013 - 01/2005
4Dyskinesias (Dyskinesia)
11/2021 - 01/2018
4Cocaine-Related Disorders (Cocaine Addiction)
11/2020 - 10/2015
4Breast Neoplasms (Breast Cancer)
03/2010 - 01/2003
3Alcoholism (Alcohol Abuse)
10/2019 - 06/2015
3Chronic Pain
12/2015 - 05/2009
2Respiratory Insufficiency (Respiratory Failure)
01/2022 - 01/2018
2Opioid-Related Disorders (Opiate Addiction)
01/2021 - 01/2018
2Bipolar Disorder (Manic Depressive Psychosis)
08/2020 - 01/2019
2Hypoxia (Hypoxemia)
12/2015 - 01/2005
2Inflammation (Inflammations)
12/2015 - 07/2013
2Acute Pain
11/2011 - 03/2011
1Hyperphagia (Overeating)
01/2022
1Binge Drinking
10/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Personality Disorders (Personality Disorder)
01/2019
1Heroin Dependence (Heroin Abuse)
01/2018
1Tics (Tic)
10/2017
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2015
1Cold Hypersensitivity
03/2013
1Nervous System Diseases (Neurological Disorders)
01/2013
1Neuroblastoma
12/2011
1Carcinogenesis
07/2009
1Carcinoma (Carcinomatosis)
07/2009
1Lung Neoplasms (Lung Cancer)
07/2009
1Mononeuropathies (Mononeuritis Multiplex)
05/2009
1Neuralgia (Stump Neuralgia)
05/2009
1Hypercholesterolemia
03/2006
1Cardiovascular Diseases (Cardiovascular Disease)
03/2006
1Alzheimer Disease (Alzheimer's Disease)
03/2006

Drug/Important Bio-Agent (IBA)

17NociceptinIBA
11/2021 - 01/2011
9LigandsIBA
01/2022 - 05/2009
9Opioid Receptors (Opioid Receptor)IBA
11/2021 - 12/2009
7Opioid Analgesics (Opioids)IBA
01/2022 - 05/2009
5Nociceptin ReceptorIBA
12/2020 - 12/2009
4Levodopa (L Dopa)FDA LinkGeneric
11/2021 - 01/2018
4Opioid Peptides (Opioid Peptide)IBA
01/2021 - 01/2018
4mu Opioid Receptors (mu Opioid Receptor)IBA
11/2020 - 12/2009
4NicotineFDA Link
01/2020 - 10/2015
4Analgesics (Analgesic Drugs)IBA
12/2015 - 12/2009
4Morphine (MS Contin)FDA LinkGeneric
12/2015 - 05/2009
3at-403IBA
01/2022 - 01/2018
3Peptides (Polypeptides)IBA
11/2021 - 08/2020
3Buprenorphine (Subutex)FDA LinkGeneric
01/2018 - 03/2011
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2017 - 03/2015
3larazotide acetateIBA
10/2015 - 04/2015
3Messenger RNA (mRNA)IBA
03/2010 - 01/2005
2GTP-Binding Proteins (G-Protein)IBA
01/2022 - 11/2021
2NeuropeptidesIBA
01/2020 - 05/2016
2Cocaine (Cocaine HCl)IBA
10/2015 - 03/2011
22- (N- cyclopropylmethyl- 4,5- epoxy- 6,14- ethano- 3- hydroxy- 6- methoxymorphinan- 7- yl)- 3,3- dimethylpentan- 2- olIBA
07/2013 - 03/2011
2SR 14150IBA
11/2011 - 05/2009
2Hormones (Hormone)IBA
03/2010 - 12/2007
2EnzymesIBA
12/2007 - 01/2003
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2006 - 01/2005
2TeaIBA
03/2006 - 01/2005
16'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA
01/2022
1Oxidopamine (6 Hydroxydopamine)IBA
11/2021
1Methylphenidate (Ritalin)FDA LinkGeneric
08/2020
1cis- 1- methyl- 7- ((4- (2,6- dichlorophenyl)piperidin- 1- yl)methyl)- 6,7,8,9- tetrahydro- 5H- benzocyclohepten- 5- olIBA
10/2019
1Pharmaceutical PreparationsIBA
10/2019
1Explosive Agents (Explosives)IBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
05/2016
1Varenicline (Chantix)FDA Link
04/2015
18- (bis(2- methylphenyl)methyl)- 3- phenyl- 8- azabicyclo(3.2.1)octan- 3- olIBA
07/2013
11- (1- (2,3,3alpha,4,5,6- hexahydro- 1H- phenalen- 1- yl)piperidin- 4- yl)indolin- 2- oneIBA
07/2013
1Peptide Receptors (Peptide Receptor)IBA
07/2013
1Ion Channels (Ion Channel)IBA
03/2013
1MentholFDA Link
03/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2011
1matrigelIBA
03/2010
1Proteins (Proteins, Gene)FDA Link
03/2010
1Tissue Inhibitor of Metalloproteinase-2IBA
03/2010
1SR 13179IBA
03/2010
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2010
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2009
1Cell Cycle ProteinsIBA
07/2009
1Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2009
1SR13904IBA
07/2009
1PPAR deltaIBA
07/2009
1Cyclin AIBA
07/2009
121- (2- N,N- diethylaminoethyl)oxy- 7- methyl- 19- norpregna- 1,3,5(10)- triene- 3- O- sulfamateIBA
12/2007
1SteroidsIBA
12/2007
1Selective Estrogen Receptor Modulators (SERM)IBA
12/2007
1Estrogen Receptor Modulators (Antiestrogen)IBA
12/2007
1Steryl-Sulfatase (Steroid Sulfatase)IBA
12/2007
1Estrogen Receptor alphaIBA
12/2007
1Catechin (Z 7300)IBA
03/2006

Therapy/Procedure

7Drug Therapy (Chemotherapy)
08/2020 - 01/2011
5Therapeutics
01/2021 - 12/2007
2Analgesia
01/2021 - 07/2013
2Self Administration (Administration, Self)
01/2016 - 10/2015
1Deep Brain Stimulation
01/2016
1Ligation
11/2011
1Chemoprevention
03/2006